Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0948265 (
metabolic syndrome
)
24,271
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Premature coronary artery disease (PCAD) is known to have a particularly strong genetic component. We aimed to investigate the association between angiotensin II receptor type 1 (ATR1) or type II (
ATR2
) genes polymorphisms and PCAD with or without
metabolic syndrome
in males. 132 male patients with PCAD and 132 controls were included in the study. ATR1 and
ATR2
genes polymorphisms were analyzed by polymerase chain reaction. The present study revealed that ATR1 CC genotype and
ATR2
G allele increased the risk of PCAD by 2.9 and 1.3 respectively as well as they increased susceptibility to
metabolic syndrome
by 4.5 and 2.3 respectively. The present study proved that diabetes, smoking, obesity, total cholesterol, triglycerides, LDLc and HDLc were independent risk factors for the development of PCAD. We concluded that ATR1 CC genotype and
ATR2
G allele increased the susceptibility of Egyptian males to have PCAD. The increased susceptibility to have
metabolic syndrome
could be one of the mechanisms leading to the development of PCAD in subjects carrying one or both of these polymorphisms.
...
PMID:Association of angiotensin II type I and type II receptor genes polymorphisms with the presence of premature coronary disease and metabolic syndrome. 2438 1